Delivery Order SPE2DB20D1109-SPE2DB23FM94C
Award Date 10/24/22
Potential Completion Date 10/25/22
Potential Value $40K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,589.60 firm fixed-price contract is for the supply of the RotaTeq vaccine, a critical medical product used for the prevention of rotavirus infections. The contract has a ceiling value of $20,589.60 and a completion date of June 8, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the RotaTeq vaccine in 2 milliliter doses. The $1,992.88 firm-fixed-price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,370.61, is for the supply of the ROTATEQ vaccine in 2-milliliter doses. It is a firm-fixed-price, non-set-aside contract with a completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- The U.S. Defense Logistics Agency (DLA) awarded a $38,380.44 firm fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of RotaTeq vaccine (2 mL). This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RotaTeq vaccine in 2ML vials. This is a firm fixed-price delivery order with a ceiling value of $4,957.32 and an ultimate completion date of November 4, 2025. The contract utilizes no set-aside designation and represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance will take place at the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999.70, is for the delivery of the RotaTeq vaccine in 2 ml doses. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This is a $2,663.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine. The delivery order is not set aside and has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 ml vials. The contract has a total ceiling value of $1,009.64 and runs through August 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these critical vaccine supplies to support military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The order is for the RotaTeq vaccine, a 2-milliliter rotavirus vaccine, with a firm fixed price of $2,524.05 and a completion date of August 9, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of the RotaTeq vaccine in 2 milliliter doses, with a ceiling value of $1,920.14 and a period of performance through March 26, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...